Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"

Luigi Di Biase¹, Prasant Mohanty¹, Sanghamitra Mohanty¹, Pasquale Santangeli¹, Chintan Trivedi¹, Dhanunjaya Lakkireddy¹, Madhu Reddy¹, Pierre Jais¹, Sakis Themistoclakis¹, Antonio Dello Russo¹, Michela Casella¹, Gemma Pelargonio¹, Maria Lucia Narducci¹, Robert Schweikert¹, Petr Neuzil¹, Javier Sanchez¹, Rodney Horton¹, Salwa Beheiry¹, Richard Hongo¹, Steven Hao¹, Antonio Rossillo¹, Giovanni Forleo¹, Claudio Tondo¹, J David Burkhardt¹, Michel Haissaguerre¹, Andrea Natale¹

Affiliations

Affiliation

¹ From Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin (L.D.B., P.M., S.M., P.S., C.T., J.S., R.H., J.D.B., A.N.); Albert Einstein College of Medicine, at Montefiore Hospital, New York, NY (L.D.B.); Department of Biomedical Engineering, University of Texas, Austin (L.D.B., A.N.); Department of Cardiology, University of Foggia, Italy (L.D.B.); University of Kansas, Kansas City (D.L., M.R.); Hôpital Cardiologique du Haut Lévêque, Université Victor-Segalen Bordeaux, France (P.J., M.H.); Ospedale dell'Angelo, Mestre Venice, Italy (S.T., A.R.); Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino IRCCS, Milan, Italy (A.D.R., M.C., C.T.); University of Sacred Heart, Rome, Italy (G.P., M.L.N.); Akron General Hospital, Ohio (R.S.); Department of Cardiology, Na Homolce Hospital, Roentgenova 2, Prague, Czech Republic (P.N.); California Pacific Medical Center, San Francisco (S.B., R.H., S.H., A.N.); University of Tor Vergata, Rome, Italy (G.F.); Division of Cardiology, Stanford University, Palo Alto, CA (A.N.); Case Western Reserve University, Cleveland, OH (A.N.); Scripps Clinic, San Diego, CA(A.N.); and Dell Medical School, Austin, TX (A.N.).

PMID: 27601565
DOI: 10.1161/CIRCULATIONAHA.116.024003

Comment

Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"

Luigi Di Biase et al. Circulation. 2016.

. 2016 Sep 6;134(10):e189-90.

doi: 10.1161/CIRCULATIONAHA.116.024003.

Authors

Affiliation

¹ From Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin (L.D.B., P.M., S.M., P.S., C.T., J.S., R.H., J.D.B., A.N.); Albert Einstein College of Medicine, at Montefiore Hospital, New York, NY (L.D.B.); Department of Biomedical Engineering, University of Texas, Austin (L.D.B., A.N.); Department of Cardiology, University of Foggia, Italy (L.D.B.); University of Kansas, Kansas City (D.L., M.R.); Hôpital Cardiologique du Haut Lévêque, Université Victor-Segalen Bordeaux, France (P.J., M.H.); Ospedale dell'Angelo, Mestre Venice, Italy (S.T., A.R.); Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino IRCCS, Milan, Italy (A.D.R., M.C., C.T.); University of Sacred Heart, Rome, Italy (G.P., M.L.N.); Akron General Hospital, Ohio (R.S.); Department of Cardiology, Na Homolce Hospital, Roentgenova 2, Prague, Czech Republic (P.N.); California Pacific Medical Center, San Francisco (S.B., R.H., S.H., A.N.); University of Tor Vergata, Rome, Italy (G.F.); Division of Cardiology, Stanford University, Palo Alto, CA (A.N.); Case Western Reserve University, Cleveland, OH (A.N.); Scripps Clinic, San Diego, CA(A.N.); and Dell Medical School, Austin, TX (A.N.).

PMID: 27601565
DOI: 10.1161/CIRCULATIONAHA.116.024003

No abstract available

PubMed Disclaimer

Comment on

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Di Biase L, et al. Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30. Circulation. 2016. PMID: 27029350 Clinical Trial.
Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Turco P. Turco P. Circulation. 2016 Sep 6;134(10):e179-80. doi: 10.1161/CIRCULATIONAHA.116.023135. Circulation. 2016. PMID: 27601560 No abstract available.
Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Willey JZ, Biviano A. Willey JZ, et al. Circulation. 2016 Sep 6;134(10):e181-2. doi: 10.1161/CIRCULATIONAHA.116.023261. Circulation. 2016. PMID: 27601561 No abstract available.
Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Kosiuk J, Hindricks G, Bollmann A. Kosiuk J, et al. Circulation. 2016 Sep 6;134(10):e183-4. doi: 10.1161/CIRCULATIONAHA.116.023334. Circulation. 2016. PMID: 27601562 No abstract available.
Letter from Liu and Yang Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Liu W, Yang XJ. Liu W, et al. Circulation. 2016 Sep 6;134(10):e185-6. doi: 10.1161/CIRCULATIONAHA.116.022820. Circulation. 2016. PMID: 27601563 No abstract available.
Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
Skolnik N. Skolnik N. Circulation. 2016 Sep 6;134(10):e187-8. doi: 10.1161/CIRCULATIONAHA.116.023385. Circulation. 2016. PMID: 27601564 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"

Affiliation

Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"

Authors

Affiliation

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical